1-3 of 3
Tushar D. Bhagat
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Phase II Study of the ALK5 Inhibitor Galunisertib in Very Low-, Low-, and Intermediate-Risk Myelodysplastic Syndromes

Valeria Santini, David Valcárcel, Uwe Platzbecker, Rami S. Komrokji, Ann L. Cleverly, Michael M. Lahn, Jan Janssen, Yumin Zhao, Alan Chiang, Aristoteles Giagounidis, Susan C. Guba, Ivelina Gueorguieva, Allicia C. Girvan, Mariana da Silva Ferreira, Tushar D. Bhagat, Kith Pradhan, Ulrich Steidl, Ashwin Sridharan, Britta Will, Amit Verma
Journal: Clinical Cancer Research
Clin Cancer Res (2019) 25 (23): 6976–6985.
https://doi.org/10.1158/1078-0432.CCR-19-1338
Published: 02 December 2019
View article titled, Phase II Study of the ALK5 Inhibitor Galunisertib in Very Low-, Low-, and Intermediate-Risk Myelodysplastic Syndromes
Open the PDF for Phase II Study of the ALK5 Inhibitor Galunisertib in Very Low-, Low-, and Intermediate-Risk Myelodysplastic Syndromes in another window
Includes: Supplementary data
Journal Articles

Loss of Function of DOCK4 in Myelodysplastic Syndromes Stem Cells is Restored by Inhibitors of DOCK4 Signaling Networks

Sriram Sundaravel, Wen-Liang Kuo, Jong Jin Jeong, Gaurav S. Choudhary, Shanisha Gordon-Mitchell, Hui Liu, Tushar D. Bhagat, Kathy L. McGraw, Sandeep Gurbuxani, Alan F. List, Amit Verma, Amittha Wickrema
Journal: Clinical Cancer Research
Clin Cancer Res (2019) 25 (18): 5638–5649.
https://doi.org/10.1158/1078-0432.CCR-19-0924
Published: 13 September 2019
View article titled, Loss of Function of DOCK4 in Myelodysplastic Syndromes Stem Cells is Restored by Inhibitors of DOCK4 Signaling Networks
Open the PDF for Loss of Function of DOCK4 in Myelodysplastic Syndromes Stem Cells is Restored by Inhibitors of DOCK4 Signaling Networks in another window
Includes: Supplementary data
Journal Articles

Kidney Cancer Is Characterized by Aberrant Methylation of Tissue-Specific Enhancers That Are Prognostic for Overall Survival

Caroline Y. Hu, Davoud Mohtat, Yiting Yu, Yi-An Ko, Niraj Shenoy, Sanchari Bhattacharya, Maria C. Izquierdo, Ae Seo Deok Park, Orsolya Giricz, Nishanth Vallumsetla, Krishna Gundabolu, Kristin Ware, Tushar D. Bhagat, Masako Suzuki, James Pullman, X. Shirley Liu, John M. Greally, Katalin Susztak, Amit Verma
Journal: Clinical Cancer Research
Clin Cancer Res (2014) 20 (16): 4349–4360.
https://doi.org/10.1158/1078-0432.CCR-14-0494
Published: 13 August 2014
View article titled, Kidney Cancer Is Characterized by Aberrant Methylation of Tissue-Specific Enhancers That Are Prognostic for Overall Survival
Open the PDF for Kidney Cancer Is Characterized by Aberrant Methylation of Tissue-Specific Enhancers That Are Prognostic for Overall Survival in another window
Includes: Supplementary data